Design Exhibition, "From Master's Thesis to Medicine Cabinet"
ePT--the Electronic Newsletter of Pharmaceutical Technology
Design Exhibition, ?From Master?s Thesis to Medicine Cabinet?
On Oct. 29, the School of Visual Arts (SVA, New York, NY, www.schoolofvisualarts.edu) opens “ClearRx: From Master’s Thesis to Medicine Cabinet,” an exhibition chronicling the evolution of an idea from a student’s graduate project on prescription bottle design to Target’s May 2005 roll-out of its ClearRx packaging. The exhibition runs through November 23 at the Westside Gallery, 141 West 21st Street, New York.
The designer, Deborah Adler (now at Milton Glaser, Inc. in New York), took on the safety-focused re-design when here grandmother, confused by the similarity of the standard amber pill-bottles, accidentally took her husband’s medication.
The ClearRx system will also be on view in the Museum of Modern Art (New York, NY, www.moma.org) exhibition, “SAFE: Design Takes on Risk,” Oct. 16, 2005 through January 2, 2006.
–Douglas McCormick
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Prokaryotics Licenses Gram-Negative Antibiotic Potentiator from Northern Antibiotics
June 26th 2025Prokaryotics will gain worldwide rights to develop, manufacture, and commercialize NAB741, a non-bioactive polymyxin designed to increase permeability of the outer membrane of Gram-negative bacteria.
